Evidence map›Paper›PMID 21124831›Full record

ArticlePloS one2010

Cucurbitacin I inhibits cell motility by indirectly interfering with actin dynamics.

David A Knecht, Rebecca A LaFleur, Alem W Kahsai, Christian E Argueta, Anwar B Beshir, Gabriel Fenteany

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

David A KnechtDepartment of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut, USA. david.knecht@uconn.edu
Rebecca A LaFleur
Alem W Kahsai
Christian E Argueta
Anwar B Beshir
Gabriel Fenteany
University of Connecticut · US

Funding

Molecular Genetics of the CytoskeletonR01GM040599 · NIGMS · UNIVERSITY OF CONNECTICUT STORRS · PI KNECHT, DAVID A · 1988 to 2009
$1.8M
Mechanism of Action of New Inhibitors of Cell MigrationR01GM077622 · NIGMS · UNIVERSITY OF CONNECTICUT STORRS · PI FENTEANY, GABRIEL · 2006 to 2010
$1.6M
NIGMS NIH HHS GM040599NIGMS NIH HHS GM077622NIGMS NIH HHS R01 GM040599NIGMS NIH HHS R01 GM077622
6 · The paper itself

Abstract

backgroundCucurbitacins are plant natural products that inhibit activation of the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway by an unknown mechanism. They are also known to cause changes in the organization of the actin cytoskeleton. METHODOLOGY/PRINCIPAL

findingsWe show that cucurbitacin I potently inhibits the migration of Madin-Darby canine kidney (MDCK) cell sheets during wound closure, as well as the random motility of B16-F1 mouse melanoma cells, but has no effect on movement of Dictyostelium discoideum amoebae. Upon treatment of MDCK or B16-F1 cells with cucurbitacin I, there is a very rapid cessation of motility and gradual accumulation of filamentous actin aggregates. The cellular effect of the compound is similar to that observed when cells are treated with the actin filament-stabilizing agent jasplakinolide. However, we found that, unlike jasplakinolide or phallacidin, cucurbitacin I does not directly stabilize actin filaments. In in vitro actin depolymerization experiments, cucurbitacin I had no effect on the rate of actin filament disassembly at the nanomolar concentrations that inhibit cell migration. At elevated concentrations, the depolymerization rate was also unaffected, although there was a delay in the initiation of depolymerization. Therefore, cucurbitacin I targets some factor involved in cellular actin dynamics other than actin itself. Two candidate proteins that play roles in actin depolymerization are the actin-severing proteins cofilin and gelsolin. Cucurbitacin I possesses electrophilic reactivity that may lead to chemical modification of its target protein, as suggested by structure-activity relationship data. However, mass spectrometry revealed no evidence for modification of purified cofilin or gelsolin by cucurbitacin I. CONCLUSIONS/SIGNIFICANCE: Cucurbitacin I results in accumulation of actin filaments in cells by a unique indirect mechanism. Furthermore, the proximal target of cucurbitacin I relevant to cell migration is unlikely to be the same one involved in activation of the JAK2/STAT3 pathway.

Indexed as

Actin CytoskeletonActin Depolymerizing FactorsActinsAnimalsAntineoplastic AgentsCell LineCell Line, TumorCell MovementCytoskeletonDepsipeptidesDictyosteliumDose-Response Relationship, DrugGelsolinMicroscopy, ConfocalMolecular Dynamics SimulationMolecular StructureActin Depolymerizing FactorsActinsAntineoplastic Agentscucurbitacin IDepsipeptidesGelsolinjasplakinolidePeptides, CyclicphallacidinTriterpenes

Identifiers

PMID21124831
PMCPMC2991314
OpenAlexW1989183491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.